Nathan Cohen

Nathan focuses on growth equity investments in healthcare, including healthcare services, pharma services, healthcare IT, medical devices, and digital health. Nathan is actively involved with Norwest’s investments in American Endovascular & Amputation Prevention, Elligo Health Research, Kyo, Mindful Health Solutions, and RiverMend Health.

Before joining Norwest, Nathan was an analyst in the healthcare investment banking group at J.P. Morgan in San Francisco. In this role, he advised companies across the healthcare sector on mergers & acquisitions, equity financings, and other strategic opportunities. Prior to that, Nathan was in the equity capital markets group at J.P. Morgan in New York, covering healthcare and pricing more than ten initial public offerings.

Nathan holds a bachelor of science in business administration with concentrations in finance and accounting, magna cum laude, from the University of Richmond’s Robins School of Business.